Vincent P. Hradil

Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI

C.-L. Chin, Ann Tovcimak, Vincent P. Hradil et al. · British Journal of Pharmacology · 2007 · 97 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3 H-thiazol-(2 Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging

Betty Yao, Gin C. Hsieh, A.V. Daza et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 91 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease

Feng Luo, Nathan R. Rustay, Ulrich Ebert et al. · Neurobiology of Aging · 2010 · 90 citations

Medicine, Neurobiology, Neuroscience +16

Potentiation of Temozolomide Cytotoxicity by Poly(ADP)Ribose Polymerase Inhibitor ABT-888 Requires a Conversion of Single-Stranded DNA Damages to Double-Stranded DNA Breaks

Xuesong Liu, Yan Shi, Ran Guan et al. · Molecular Cancer Research · 2008 · 76 citations

Life Sciences, Cancer Biology, Molecular Biology +17

Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats

Pamela D. Skoubis, Vincent P. Hradil, C.-L. Chin et al. · Neuroscience · 2005 · 46 citations

Life Sciences, Neuroscience, Pharmacology +16